Literature DB >> 6242558

Antihypertensive and aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascular hypertension.

M Volpe, G Odell, H D Kleinert, M J Camargot, J H Laragh, J A Lewicki, T Maack, E D Vaughan, S A Atlas.   

Abstract

A 24-amino acid residue synthetic atrial natriuretic factor (ANF) antagonizes angiotensin II-induced vascular contractility and aldosterone production in isolated blood vessels and adrenal cells, respectively. To determine the significance of these effects in vivo, the blood pressure and aldosterone responses to synthetic ANF were evaluated in rats with two-kidney, one clip hypertension (n = 5) and in sham-operated controls (n = 4). In the latter, ANF caused a slight fall in mean blood pressure (-7 +/- 3%) and inconsistent changes in plasma renin and aldosterone. In hypertensive rats, ANF decreased blood pressure by 31 +/- 7 mmHg (17 +/- 3%), comparable to the effect of the angiotensin antagonist saralasin (31 +/- 4 mmHg). Plasma renin activity increased from 48 +/- 15 to 79 +/- 23 ng/ml/h. Despite this, ANF caused marked suppression of plasma aldosterone (from 97 +/- 28 to 20 +/- 8.9 ng/100 ml). These results show that ANF can exert potent antihypertensive and aldosterone-lowering effects in vivo, at least when the renin-angiotensin system is stimulated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6242558

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  2 in total

Review 1.  [Atrial natriuretic peptide and its significance for arterial hypertension].

Authors:  G Wambach; M Stimpel; G Bönner
Journal:  Klin Wochenschr       Date:  1989-11-03

2.  Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors.

Authors:  H J Kramer; B Lichardus
Journal:  Klin Wochenschr       Date:  1986-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.